HealthExpress in the news

New vaccine for the herpes virus successful in animal study

05/10/2011 | Herpes Virus |
Vaccine vial and syringe

A new vaccine created to fight the herpes simplex virus has shown positive results in a round of animal studies conducted on guinea pigs.

Vical, the manufacturer of the plasmid DNA vaccine, named Vaxfectin, presented the results of the trial in Seattle, Washington, at the Vaccine and International Society for Vaccines Annual Global Congress. The results showed that the vaccine protected the guinea pigs from both primary and recurrent variations of the herpes simplex virus. It was also shown to reduce both viral shedding and the recurrence of genital lesions to a significant degree, as well as reducing latent infection in the central nervous system.


Read More

Featured News
Girl crying on a bench

London borough identified as having En..

The London borough of Islington has one of the highest rates for STIs in England, and has the most.. More..

Herpes virus could lead to future drug..

Experts believe that a rare, but dangerous, reaction to a range of medications could be the result.. More..